| Dr Andrew J Mclean, MD | |
|
2624 9th Ave S, Fargo, ND 58103-2350 | |
| (701) 298-4500 | |
| (701) 298-4400 |
| Full Name | Dr Andrew J Mclean |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 2624 9th Ave S, Fargo, North Dakota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881627727 | NPI | - | NPPES |
| 4H106MC | Other | MN | BCBS OF MN PIN |
| 011578 | Other | ND | BCBS OF ND PIN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | ND 6489 (North Dakota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Andrew J Mclean, MD 2624 9th Ave S, Fargo, ND 58103-2350 Ph: (701) 298-4500 | Dr Andrew J Mclean, MD 2624 9th Ave S, Fargo, ND 58103-2350 Ph: (701) 298-4500 |
News Archive
Overexpression of a specific type of microRNA can derail treatment by disabling an important molecular brake on breast cancer cell proliferation, according to evidence presented by researchers from The University of Texas M. D. Anderson Cancer Center at the American Association for Cancer Research 101st Annual Meeting 2010.
FluimediX, a point-of-care diagnostic company, announced today that it has received funding for the continued development of the NanoCycler, a diagnostic platform for the measurement of relevant genetic mutations in patients. The proceeds of this financing round will be dedicated to developing a diagnostic test for Warfarin™ metabolism.
MedMira Inc., the international market leader in rapid flow- through diagnostic technology announced today that it has begun shipment of its MiraWell(TM) Rapid HIV Test to its distributor.
Human Pheromone Sciences, Inc. today announced results for the first quarter ended March 31, 2010. Net revenues of $185,000 represented a 12% increase from the revenues of $165,000 in the prior year period, and resulted in a net loss of $98,000 ($.02 per share) as compared with net loss of $181,000 ($.04 per share) for the same period in 2009.
The European Union has approved the use of the breast cancer drug Herceptin for use in patients with an early stage of the aggressive HER2-positive type of breast cancer.
› Verified 1 days ago
Susan L Scarberry, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 700 1st Ave S, Fargo, ND 58103 Phone: 701-234-4036 Fax: 701-234-4160 | |
Charlotte Marie Andersen, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 510 4th Street S, Fargo, ND 58107 Phone: 701-476-7200 | |
Dr. Lawana Marie Burtnett, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 510 4th St S, Fargo, ND 58103 Phone: 701-476-7200 | |
Dr. Ravinda Samaraweera, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 700 1st Ave S, Fargo, ND 58103 Phone: 701-234-4036 Fax: 701-234-4160 | |
Dr. Timothy T Vo, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 2624 9th Ave S, Southeast Human Service Center, Fargo, ND 58103 Phone: 701-298-4500 Fax: 701-298-4400 | |
Karis Antonia Stenback Irving, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2101 Elm St Ne, Fargo, ND 58102 Phone: 615-918-0639 Fax: 612-749-3990 | |
Amna Masood, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 736 Broadway N, Fargo, ND 58102 Phone: 701-234-2000 Fax: 701-234-2345 |